THERAVANCE INC - COMMON STOCK (THRX)

CUSIP: 88338T104

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COMMON STOCK
Total 13F shares
88,982,700
Share change
+6,753,348
Total reported value
$2,752,975,356
Put/Call ratio
93%
Price per share
$30.94
Number of holders
140
Value change
+$199,262,896
Number of buys
79
Number of sells
72

Quarterly Holders Quick Answers

What is CUSIP 88338T104?
CUSIP 88338T104 identifies THRX - THERAVANCE INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAVANCE INC - COMMON STOCK (THRX) as of Q1 2014

As of 31 Mar 2014, THERAVANCE INC - COMMON STOCK (THRX) was held by 140 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 88,982,700 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, Capital World Investors, IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, OPPENHEIMER FUNDS INC, CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD, ALLIANCEBERNSTEIN L.P., BlackRock Fund Advisors, and BlackRock Institutional Trust Company, N.A.. This page lists 140 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.